DISABILITY IN LEPROSY – A RETROSPECTIVE, DESCRIPTIVE AND ANALYTIC STUDY OF 243 PATIENTS TREATED BEFORE AND AFTER THE INTRODUCTION OF MULTIDRUG THERAPY BY THE WHO

Detalhes bibliográficos
Autor(a) principal: Laureano, André
Data de Publicação: 2014
Outros Autores: Vieira, Raquel, Medeiros, Sandra, Pacheco, Fernando Assis, Cardoso, Jorge
Tipo de documento: Artigo
Idioma: por
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://doi.org/10.29021/spdv.72.3.274
Resumo: Introduction: Disability in leprosy may result from peripheral nerve injury. Prevention of disabilities represents one of the major goals of treatment programs.Objectives: Description and comparison of two groups of leprosy patients treated before (“old” patients) and after (“new” patients) multidrug treatment implementation by the World Health Organization, analyzing its potential impact in disability reduction.Materials and methods: Retrospective, descriptive and analytic study of 243 patients distributed in two groups: 164 “old” patient” and 79 “new” patients. Sex, age at diagnosis, time between the onset of symptoms and diagnosis, clinical forms, bacilloscopy, early neurological symptoms, lenght of treatment and occurrence of reaction phenomena were studied. Disabilities were assessed using the World Health Organization disability grading system at least five years after stopping antileprosy treatment. Statistical analysis was performed using software SPSS.18. Chi-square, Mann-Whitney and Kruskal-Wallis tests were used.Results: Disability was more frequent in “old” patients with statistically significant difference in males, BL clinical form, positive basillocopy and neurological symptoms at the onset, and in patients with reaction phenomena. Severe disabilty grades were also superior in “old” patients. There was no relation between the lenght of treatment and disability.Conclusion: Prevention of disabilities is possible by an early diagnosis and proper treatment with multidrug treatment proposed by the World Health Organization.
id RCAP_d9fc912e2e91e0f5819f9740050be66c
oai_identifier_str oai:ojs.revista.spdv.com.pt:article/274
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling DISABILITY IN LEPROSY – A RETROSPECTIVE, DESCRIPTIVE AND ANALYTIC STUDY OF 243 PATIENTS TREATED BEFORE AND AFTER THE INTRODUCTION OF MULTIDRUG THERAPY BY THE WHOINCAPACIDADE FUNCIONAL NA DOENÇA DE HANSEN – ESTUDO RETROSPECTIVO, DESCRITIVO, E ANALÍTICO DE 243 DOENTES TRATADOS ANTES E DEPOIS DA TERAPÊUTICA DA OMSDisability evaluationLeprosyMotor activityWorld Health OrganizationLepraActividade motoraAvaliação da incapacidadeOrganização Mundial de SaúdeIntroduction: Disability in leprosy may result from peripheral nerve injury. Prevention of disabilities represents one of the major goals of treatment programs.Objectives: Description and comparison of two groups of leprosy patients treated before (“old” patients) and after (“new” patients) multidrug treatment implementation by the World Health Organization, analyzing its potential impact in disability reduction.Materials and methods: Retrospective, descriptive and analytic study of 243 patients distributed in two groups: 164 “old” patient” and 79 “new” patients. Sex, age at diagnosis, time between the onset of symptoms and diagnosis, clinical forms, bacilloscopy, early neurological symptoms, lenght of treatment and occurrence of reaction phenomena were studied. Disabilities were assessed using the World Health Organization disability grading system at least five years after stopping antileprosy treatment. Statistical analysis was performed using software SPSS.18. Chi-square, Mann-Whitney and Kruskal-Wallis tests were used.Results: Disability was more frequent in “old” patients with statistically significant difference in males, BL clinical form, positive basillocopy and neurological symptoms at the onset, and in patients with reaction phenomena. Severe disabilty grades were also superior in “old” patients. There was no relation between the lenght of treatment and disability.Conclusion: Prevention of disabilities is possible by an early diagnosis and proper treatment with multidrug treatment proposed by the World Health Organization.Introdução: A doença de Hansen pode resultar em incapacidade funcional pelo compromisso do sistema nervoso periférico. A prevenção de incapacidade constitui o objectivo dos actuais programas de tratamento, nomeadamente da terapêutica tripla da Organização Mundial de Saúde.Objectivos: Caracterizar e comparar dois grupos de doentes de Hansen, tratados antes (“antigos”) e depois (“recentes”) da introdução da terapêutica tripla da Organização Mundial de Saúde, analisando o benefício desta na redução de incapacidade. Identificar as características dos doentes mais favorecidos nesta potencial redução e, nos doentes “recentes”, determinar se o prolongamento da duração da terapêutica beneficia a redução de incapacidade.Material e Métodos: Estudo retrospectivo e comparativo de 243 doentes, distribuídos em dois grupos, 164 “antigos” e 79 “recentes”, caracterizados quanto ao sexo, idade à data do diagnóstico, intervalo entre início de sintomas e diagnóstico, forma clínica (Ridley e Jopling), ocorrência de reacção, índice bacteriológico (IB) inicial, presença de sintomas neurológicos iniciais, duração da terapêutica anti-leprótica e presença e grau de incapacidade.Resultados: A comparação da presença de incapacidade nos dois grupos mostrou que esta é mais elevada nos doentes “antigos”, sendo significativamente superior no sexo masculino, forma lepromatosa borderline, ocorrência de reacção, IB inicial positivo e com sintomas neurológicos iniciais. A incapacidade grau 2 é também significativamente superior nos doentes “antigos” . Nos doentes “recentes” não se verificou relação entre a duração da terapêutica da Organização Mundial de Saúde e a presença de incapacidade.Conclusão: A prevenção e redução de incapacidade na doença de Hansen é possível através de um diagnóstico precoce e tratamento adequado com a terapêutica tripla da Organização Mundial de Saúde.Sociedade Portuguesa de Dermatologia e Venereologia2014-10-12T00:00:00Zjournal articleinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://doi.org/10.29021/spdv.72.3.274oai:ojs.revista.spdv.com.pt:article/274Journal of the Portuguese Society of Dermatology and Venereology; Vol 72 No 3 (2014): Julho - Setembro; 325-331Revista da Sociedade Portuguesa de Dermatologia e Venereologia; v. 72 n. 3 (2014): Julho - Setembro; 325-3312182-24092182-2395reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://revista.spdv.com.pt/index.php/spdv/article/view/274https://doi.org/10.29021/spdv.72.3.274https://revista.spdv.com.pt/index.php/spdv/article/view/274/269Laureano, AndréVieira, RaquelMedeiros, SandraPacheco, Fernando AssisCardoso, Jorgeinfo:eu-repo/semantics/openAccess2022-10-06T12:34:48Zoai:ojs.revista.spdv.com.pt:article/274Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:10:48.829371Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv DISABILITY IN LEPROSY – A RETROSPECTIVE, DESCRIPTIVE AND ANALYTIC STUDY OF 243 PATIENTS TREATED BEFORE AND AFTER THE INTRODUCTION OF MULTIDRUG THERAPY BY THE WHO
INCAPACIDADE FUNCIONAL NA DOENÇA DE HANSEN – ESTUDO RETROSPECTIVO, DESCRITIVO, E ANALÍTICO DE 243 DOENTES TRATADOS ANTES E DEPOIS DA TERAPÊUTICA DA OMS
title DISABILITY IN LEPROSY – A RETROSPECTIVE, DESCRIPTIVE AND ANALYTIC STUDY OF 243 PATIENTS TREATED BEFORE AND AFTER THE INTRODUCTION OF MULTIDRUG THERAPY BY THE WHO
spellingShingle DISABILITY IN LEPROSY – A RETROSPECTIVE, DESCRIPTIVE AND ANALYTIC STUDY OF 243 PATIENTS TREATED BEFORE AND AFTER THE INTRODUCTION OF MULTIDRUG THERAPY BY THE WHO
Laureano, André
Disability evaluation
Leprosy
Motor activity
World Health Organization
Lepra
Actividade motora
Avaliação da incapacidade
Organização Mundial de Saúde
title_short DISABILITY IN LEPROSY – A RETROSPECTIVE, DESCRIPTIVE AND ANALYTIC STUDY OF 243 PATIENTS TREATED BEFORE AND AFTER THE INTRODUCTION OF MULTIDRUG THERAPY BY THE WHO
title_full DISABILITY IN LEPROSY – A RETROSPECTIVE, DESCRIPTIVE AND ANALYTIC STUDY OF 243 PATIENTS TREATED BEFORE AND AFTER THE INTRODUCTION OF MULTIDRUG THERAPY BY THE WHO
title_fullStr DISABILITY IN LEPROSY – A RETROSPECTIVE, DESCRIPTIVE AND ANALYTIC STUDY OF 243 PATIENTS TREATED BEFORE AND AFTER THE INTRODUCTION OF MULTIDRUG THERAPY BY THE WHO
title_full_unstemmed DISABILITY IN LEPROSY – A RETROSPECTIVE, DESCRIPTIVE AND ANALYTIC STUDY OF 243 PATIENTS TREATED BEFORE AND AFTER THE INTRODUCTION OF MULTIDRUG THERAPY BY THE WHO
title_sort DISABILITY IN LEPROSY – A RETROSPECTIVE, DESCRIPTIVE AND ANALYTIC STUDY OF 243 PATIENTS TREATED BEFORE AND AFTER THE INTRODUCTION OF MULTIDRUG THERAPY BY THE WHO
author Laureano, André
author_facet Laureano, André
Vieira, Raquel
Medeiros, Sandra
Pacheco, Fernando Assis
Cardoso, Jorge
author_role author
author2 Vieira, Raquel
Medeiros, Sandra
Pacheco, Fernando Assis
Cardoso, Jorge
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Laureano, André
Vieira, Raquel
Medeiros, Sandra
Pacheco, Fernando Assis
Cardoso, Jorge
dc.subject.por.fl_str_mv Disability evaluation
Leprosy
Motor activity
World Health Organization
Lepra
Actividade motora
Avaliação da incapacidade
Organização Mundial de Saúde
topic Disability evaluation
Leprosy
Motor activity
World Health Organization
Lepra
Actividade motora
Avaliação da incapacidade
Organização Mundial de Saúde
description Introduction: Disability in leprosy may result from peripheral nerve injury. Prevention of disabilities represents one of the major goals of treatment programs.Objectives: Description and comparison of two groups of leprosy patients treated before (“old” patients) and after (“new” patients) multidrug treatment implementation by the World Health Organization, analyzing its potential impact in disability reduction.Materials and methods: Retrospective, descriptive and analytic study of 243 patients distributed in two groups: 164 “old” patient” and 79 “new” patients. Sex, age at diagnosis, time between the onset of symptoms and diagnosis, clinical forms, bacilloscopy, early neurological symptoms, lenght of treatment and occurrence of reaction phenomena were studied. Disabilities were assessed using the World Health Organization disability grading system at least five years after stopping antileprosy treatment. Statistical analysis was performed using software SPSS.18. Chi-square, Mann-Whitney and Kruskal-Wallis tests were used.Results: Disability was more frequent in “old” patients with statistically significant difference in males, BL clinical form, positive basillocopy and neurological symptoms at the onset, and in patients with reaction phenomena. Severe disabilty grades were also superior in “old” patients. There was no relation between the lenght of treatment and disability.Conclusion: Prevention of disabilities is possible by an early diagnosis and proper treatment with multidrug treatment proposed by the World Health Organization.
publishDate 2014
dc.date.none.fl_str_mv 2014-10-12T00:00:00Z
dc.type.driver.fl_str_mv journal article
info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://doi.org/10.29021/spdv.72.3.274
oai:ojs.revista.spdv.com.pt:article/274
url https://doi.org/10.29021/spdv.72.3.274
identifier_str_mv oai:ojs.revista.spdv.com.pt:article/274
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://revista.spdv.com.pt/index.php/spdv/article/view/274
https://doi.org/10.29021/spdv.72.3.274
https://revista.spdv.com.pt/index.php/spdv/article/view/274/269
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Sociedade Portuguesa de Dermatologia e Venereologia
publisher.none.fl_str_mv Sociedade Portuguesa de Dermatologia e Venereologia
dc.source.none.fl_str_mv Journal of the Portuguese Society of Dermatology and Venereology; Vol 72 No 3 (2014): Julho - Setembro; 325-331
Revista da Sociedade Portuguesa de Dermatologia e Venereologia; v. 72 n. 3 (2014): Julho - Setembro; 325-331
2182-2409
2182-2395
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799130564315316224